Spinal cord astrocytomas: Results of therapy

Howard M. Sandler, Stephen M. Papadopoulos, Allan F. Thornton, Donald (Don) Ross

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Spinal cord astrocytomas are rare lesions, usually of low grade, with a long natural history. Because of this, it is difficult to define the optimum approach to therapy based on available data. To provide more data, a retrospective review was performed. From 1975 through 1989, 21 patients were seen and treated (median age, 21 years), and 15 patients received radiation therapy after undergoing either biopsy or resection. The median time until death or the last follow-up examination was 41 months. The actuarial survival of all patients was 68% at 5 years. Of the five deaths, four were related to local tumor recurrence. The overall survival and recurrence-free survival of irradiated patients at 5 years was 57% and 44%, respectively. The age of the patient was a prognostic factor, with younger patients surviving substantially longer before recurrence. Of the 15 irradiated patients, 7 experienced recurrence of the tumor, which occurred within the irradiated portion of the spinal cord in all 7. Gross total resections were rarely achieved and, also, the extent of resection did not influence the risk for recurrence. In summary, we observed a long natural history for this disease, and although additional local therapy appears needed, it is unclear that either higher doses of radiation or more extensive surgery will decrease the risk of recurrence.

Original languageEnglish (US)
Pages (from-to)490-493
Number of pages4
JournalNeurosurgery
Volume30
Issue number4
StatePublished - 1992
Externally publishedYes

Fingerprint

Astrocytoma
Spinal Cord
Recurrence
Natural History
Therapeutics
Survival
Neoplasms
Radiotherapy
Radiation
Biopsy

Keywords

  • Astrocytomas
  • Radiotherapy
  • Spinal cord tumors

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Sandler, H. M., Papadopoulos, S. M., Thornton, A. F., & Ross, D. D. (1992). Spinal cord astrocytomas: Results of therapy. Neurosurgery, 30(4), 490-493.

Spinal cord astrocytomas : Results of therapy. / Sandler, Howard M.; Papadopoulos, Stephen M.; Thornton, Allan F.; Ross, Donald (Don).

In: Neurosurgery, Vol. 30, No. 4, 1992, p. 490-493.

Research output: Contribution to journalArticle

Sandler, HM, Papadopoulos, SM, Thornton, AF & Ross, DD 1992, 'Spinal cord astrocytomas: Results of therapy', Neurosurgery, vol. 30, no. 4, pp. 490-493.
Sandler HM, Papadopoulos SM, Thornton AF, Ross DD. Spinal cord astrocytomas: Results of therapy. Neurosurgery. 1992;30(4):490-493.
Sandler, Howard M. ; Papadopoulos, Stephen M. ; Thornton, Allan F. ; Ross, Donald (Don). / Spinal cord astrocytomas : Results of therapy. In: Neurosurgery. 1992 ; Vol. 30, No. 4. pp. 490-493.
@article{1bc5f6aaa74e413bb4deb99e3204f9a4,
title = "Spinal cord astrocytomas: Results of therapy",
abstract = "Spinal cord astrocytomas are rare lesions, usually of low grade, with a long natural history. Because of this, it is difficult to define the optimum approach to therapy based on available data. To provide more data, a retrospective review was performed. From 1975 through 1989, 21 patients were seen and treated (median age, 21 years), and 15 patients received radiation therapy after undergoing either biopsy or resection. The median time until death or the last follow-up examination was 41 months. The actuarial survival of all patients was 68{\%} at 5 years. Of the five deaths, four were related to local tumor recurrence. The overall survival and recurrence-free survival of irradiated patients at 5 years was 57{\%} and 44{\%}, respectively. The age of the patient was a prognostic factor, with younger patients surviving substantially longer before recurrence. Of the 15 irradiated patients, 7 experienced recurrence of the tumor, which occurred within the irradiated portion of the spinal cord in all 7. Gross total resections were rarely achieved and, also, the extent of resection did not influence the risk for recurrence. In summary, we observed a long natural history for this disease, and although additional local therapy appears needed, it is unclear that either higher doses of radiation or more extensive surgery will decrease the risk of recurrence.",
keywords = "Astrocytomas, Radiotherapy, Spinal cord tumors",
author = "Sandler, {Howard M.} and Papadopoulos, {Stephen M.} and Thornton, {Allan F.} and Ross, {Donald (Don)}",
year = "1992",
language = "English (US)",
volume = "30",
pages = "490--493",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Spinal cord astrocytomas

T2 - Results of therapy

AU - Sandler, Howard M.

AU - Papadopoulos, Stephen M.

AU - Thornton, Allan F.

AU - Ross, Donald (Don)

PY - 1992

Y1 - 1992

N2 - Spinal cord astrocytomas are rare lesions, usually of low grade, with a long natural history. Because of this, it is difficult to define the optimum approach to therapy based on available data. To provide more data, a retrospective review was performed. From 1975 through 1989, 21 patients were seen and treated (median age, 21 years), and 15 patients received radiation therapy after undergoing either biopsy or resection. The median time until death or the last follow-up examination was 41 months. The actuarial survival of all patients was 68% at 5 years. Of the five deaths, four were related to local tumor recurrence. The overall survival and recurrence-free survival of irradiated patients at 5 years was 57% and 44%, respectively. The age of the patient was a prognostic factor, with younger patients surviving substantially longer before recurrence. Of the 15 irradiated patients, 7 experienced recurrence of the tumor, which occurred within the irradiated portion of the spinal cord in all 7. Gross total resections were rarely achieved and, also, the extent of resection did not influence the risk for recurrence. In summary, we observed a long natural history for this disease, and although additional local therapy appears needed, it is unclear that either higher doses of radiation or more extensive surgery will decrease the risk of recurrence.

AB - Spinal cord astrocytomas are rare lesions, usually of low grade, with a long natural history. Because of this, it is difficult to define the optimum approach to therapy based on available data. To provide more data, a retrospective review was performed. From 1975 through 1989, 21 patients were seen and treated (median age, 21 years), and 15 patients received radiation therapy after undergoing either biopsy or resection. The median time until death or the last follow-up examination was 41 months. The actuarial survival of all patients was 68% at 5 years. Of the five deaths, four were related to local tumor recurrence. The overall survival and recurrence-free survival of irradiated patients at 5 years was 57% and 44%, respectively. The age of the patient was a prognostic factor, with younger patients surviving substantially longer before recurrence. Of the 15 irradiated patients, 7 experienced recurrence of the tumor, which occurred within the irradiated portion of the spinal cord in all 7. Gross total resections were rarely achieved and, also, the extent of resection did not influence the risk for recurrence. In summary, we observed a long natural history for this disease, and although additional local therapy appears needed, it is unclear that either higher doses of radiation or more extensive surgery will decrease the risk of recurrence.

KW - Astrocytomas

KW - Radiotherapy

KW - Spinal cord tumors

UR - http://www.scopus.com/inward/record.url?scp=0026752627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026752627&partnerID=8YFLogxK

M3 - Article

C2 - 1584345

AN - SCOPUS:0026752627

VL - 30

SP - 490

EP - 493

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 4

ER -